Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Andexanet alfa in patients with factor Xa inhibitor-associated intracranial hemorrhage : The prospective observational multicenter ASTRO-DE studyIn: International Journal of Stroke 2025 , in pressDOI (Open Access)
-
Prior Anticoagulation and Risk of Hemorrhagic Transformation in Acute Stroke : A Post Hoc Analysis of the PRODAST StudyIn: Journal of the American Heart Association , Jg. 14 2025, Nr. 3, e037014DOI (Open Access)
-
Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting : The PRODAST studyIn: European Stroke Journal , Jg. 9 2024, Nr. 3, S. 696 – 703DOI (Open Access)
-
Minimisation of dialysis risk in hospital patients with chronic kidney disease (MinDial) : Study protocol for a multicentre, stepped-wedge, cluster-randomised controlled trialIn: Trials , Jg. 25 2024, Nr. 1, 368DOI (Open Access)
-
Update to the study protocol: minimisation of dialysis risk in hospital patients with chronic kidney disease (MinDial) : A multicentre, stepped-wedge, cluster-randomised controlled trialIn: Trials , Jg. 25 2024, Nr. 1, 586DOI (Open Access)
-
Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA : The PRODAST studyIn: International Journal of Stroke , Jg. 18 2023, Nr. 10, S. 1169 – 1177DOI (Open Access)
-
Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists : The RIC-ICH studyIn: Frontiers in Neurology , Jg. 14 2023, 1212495DOI, Online Volltext (Open Access)
-
Controlled oxygenated rewarming as novel end-ischemic therapy for cold stored liver grafts : A randomized controlled trialIn: Clinical and Translational Science (CTS) , Jg. 15 2022, Nr. 12, S. 2918 – 2927DOI, Online Volltext (Open Access)
-
Rationale, Design and Methods of the Prospective Record of the Use of Dabigatran in Patients with Acute Stroke or TIA (PRODAST) StudyIn: European Stroke Journal , Jg. 6 2021, Nr. 4, S. 438 – 444DOI (Open Access)
-
Improving drug safety in hospitals: A retrospective study on the potential of adverse drug events coded in routine dataIn: BMC Health Services Research , Jg. 19 2019, Nr. 1, S. 555DOI, Online Volltext (Open Access)
-
Eculizumab in cold agglutinin disease (DECADE) : an open-label, prospective, bicentric, nonrandomized phase 2 trial.In: Blood Advances , Jg. 2 2018, Nr. 19, S. 2543 – 2549DOI (Open Access)
-
Adverse drug events in German hospital routine data : A validation of International Classification of Diseases, 10th revision (ICD-10) diagnostic codesIn: PLoS ONE , Jg. 12 2017, Nr. 11, S. e0187510DOI (Open Access)
-
The terminal complement inhibitor eculizumab in Cold Agglutinin Disease (CAD) : A prospective phase II trial (DECADE Trial)In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 3, S. 138 – 138
-
Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD) : Results from a Prospective Phase II Trial (DECADE Trial)In: Blood , Jg. 126 2015, Nr. 23, S. 274
-
Opportunities and pitfalls in the definition of data validityIn: Building Continents of Knowledge in Oceans of Data: The Future of Co-Created eHealth / Ugon, Adrien; Karlsson, Daniel (Hrsg.) 2018, S. 566 – 570DOI (Open Access)